ROCKET PHARMACEUTICALS INC's ticker is RCKT and the CUSIP is 77313F106. A total of 147 filers reported holding ROCKET PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2022 | $643,000 | -27.3% | 40,550 | 0.0% | 0.16% | -5.8% |
Q4 2021 | $885,000 | -27.0% | 40,550 | 0.0% | 0.17% | -9.5% |
Q3 2021 | $1,212,000 | -32.5% | 40,550 | 0.0% | 0.19% | -14.4% |
Q2 2021 | $1,796,000 | -36.5% | 40,550 | -36.4% | 0.22% | -57.5% |
Q1 2021 | $2,829,000 | -19.1% | 63,770 | 0.0% | 0.52% | +48.3% |
Q4 2020 | $3,497,000 | +53.5% | 63,770 | -36.0% | 0.35% | -44.6% |
Q3 2020 | $2,278,000 | -21.2% | 99,643 | -27.9% | 0.64% | -31.7% |
Q2 2020 | $2,892,000 | +61.7% | 138,197 | +7.8% | 0.93% | -9.6% |
Q1 2020 | $1,788,000 | – | 128,197 | – | 1.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
M28 Capital Management LP | 715,880 | $11,354,000 | 10.44% |
RTW INVESTMENTS, LP | 15,802,802 | $250,632,000 | 5.19% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 63,000 | $17,884,000 | 4.03% |
TANG CAPITAL MANAGEMENT LLC | 1,265,900 | $20,077,000 | 4.02% |
Prosight Management, LP | 203,268 | $3,224,000 | 2.08% |
COWEN AND COMPANY, LLC | 1,000,000 | $15,860,000 | 1.53% |
Boxer Capital, LLC | 1,466,051 | $23,252,000 | 1.20% |
Cormorant Asset Management, LP | 868,550 | $13,775,000 | 1.06% |
Amitell Capital Pte Ltd | 97,331 | $1,544,000 | 0.90% |
SECTORAL ASSET MANAGEMENT INC | 303,975 | $4,821,000 | 0.86% |